Xencor reported $61.58M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 10036M 518M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Alnylam Pharmaceuticals ALNY:US $ 369.31M 2.6M
Amgen AMGN:US $ 4.33B 1.37B
Arrowhead Research ARWR:US $ 103.17M 25.41M
AstraZeneca AZN:LN 11.54B 4.45B
Biogen BIIB:US $ 1984.9M 304.4M
Bristol Myers Squibb BMY:US $ 9.63B 360M
Cytokinetics CYTK:US $ 74.64M 17M
Epizyme EPZM:US $ 69.34M 1.9M
GlaxoSmithKline GSK:LN 7.14B 722M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Karyopharm Therapeutics KPTI:US $ 81.5M 9.85M
Macrogenics MGNX:US $ 68.65M 2.39M
Merk MRK:US $ 8328M 1460M
Novartis NOVN:VX 10.13B 319M
Pfizer PFE:US $ 16447M 3384M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M
Seattle Genetics SGEN:US $ 722.02M 243.94M
Xencor XNCR:US $ 61.58M 3.22M